Literature DB >> 20442512

Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets.

Ilaria Uomo, Simona Miraglia, Maurizio Pastorello.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442512

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


× No keyword cloud information.
  7 in total

1.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

Authors:  Naotake Funamizu; Chaoxin Hu; Curtis Lacy; Aaron Schetter; Geng Zhang; Peijun He; Jochen Gaedcke; Michael B Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Jeffrey Subleski; Tim Chan; Jonathan M Weiss; Timothy C Back; Katsuhiko Yanaga; Nader Hanna; H Richard Alexander; Anirban Maitra; S Perwez Hussain
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

2.  A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.

Authors:  B Karthik Grandhi; Arvind Thakkar; Jeffrey Wang; Sunil Prabhu
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-26

3.  Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis.

Authors:  Fushi Wen; Alex Shen; Andrew Choi; Eugene W Gerner; Jiaqi Shi
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

4.  Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.

Authors:  Takeo Shimasaki; Ayako Kitano; Yoshiharu Motoo; Toshinari Minamoto
Journal:  J Carcinog       Date:  2012-09-13

5.  Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion.

Authors:  Teresa A Brentnall
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

6.  The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.

Authors:  A Arlt; H Schäfer; H Kalthoff
Journal:  Oncogenesis       Date:  2012-11-26       Impact factor: 7.485

7.  Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.

Authors:  Yoshiharu Motoo; Takeo Shimasaki; Yasuhito Ishigaki; Hideo Nakajima; Kazuyuki Kawakami; Toshinari Minamoto
Journal:  Cancers (Basel)       Date:  2011-01-24       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.